Open pOssibilities
EuroAPI : Principes actifs pharmaceutiques
Watch our manifestoReinventing active ingredient solutions to sustainably meet clients’ and patients’ needs around the world.
Our Offer
With approximately €1 billion in expected sales in 2022, EUROAPI will rank #1 in small molecules APIs, and our strong innovation and R&D capabilities allow us to accelerate our development in more complex molecule segments through CDMO activities.
At approximately 200 APIs, EUROAPI offers one of the largest portfolios in the industry, addressing a wide variety of patients and providing coverage for more than 80 countries.
We provide expertise in Quality, Regulatory and Supply and have dedicated commercial teams for our clients around the globe.
Our fundamentals
We are driven by the success of our clients and their satisfaction
Who We Are, What We Do
A dedicated
Contract Development Manufacturing Organization team
CDMO
Our Commercial Network is covering 80 cOuntries and our 6 industrial sites are located in Europe
Quality and regulatory cOmpliance
-
GMP & GDP compliance.
-
High quality level throughout the manufacturing chain including raw material sourcing.
-
Strong track record with health authorities.
